Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Joint pain (arthralgia) and hot flashes are the most common side effects of letrozole, and several strategies can ease them, though the right combination depends on your symptoms and health history. Regular movement such as walking, swimming, yoga, or tai chi, along with strength training and stretching, is one of the most effective ways to reduce stiffness and aching joints, while acetaminophen or NSAIDs, warm baths, acupuncture, vitamin D correction, and maintaining a healthy weight may also help. For hot flashes, dressing in layers, keeping rooms cool, limiting alcohol, caffeine, and spicy foods, practicing paced breathing, and asking your oncologist about non-hormonal medications like venlafaxine, gabapentin, or oxybutynin can bring meaningful relief. Some people benefit from switching to a different aromatase inhibitor or taking a short supervised break rather than stopping treatment, so never discontinue letrozole on your own. There are important details, timelines, and warning signs to consider, including symptoms that need urgent evaluation, so see below to understand more.
If your joint pain, stiffness, or hot flashes are getting worse, or you are unsure whether what you feel is a medication side effect or something else, a free, instant, online symptom check can help you organize your symptoms in minutes and understand which ones deserve prompt medical attention. It takes only a few minutes, costs nothing, and gives you clearer language to bring to your next oncology visit so you can advocate for the relief you need.
Last reviewed for medical accuracy: 09/13/2026
Letrozole is an aromatase inhibitor commonly prescribed for hormone-receptor-positive breast cancer in postmenopausal women. By lowering estrogen levels, letrozole can reduce the risk of cancer recurrence—but it often brings unwelcome side effects, including joint pain (arthralgia) and hot flashes. The good news is that many strategies and treatments can ease these symptoms, helping you stay on therapy comfortably.
Regular, Gentle Exercise
Physical Therapy & Occupational Therapy
Weight Management
Over-the-Counter (OTC) Pain Relievers
Prescription Options
Hot/Cold Therapy
Supplements & Dietary Considerations
Complementary Approaches
When to Speak to Your Doctor
Lifestyle Modifications
Non-Hormonal Prescription Treatments
Supplements & Herbal Remedies
Mind-Body Techniques
Tracking & Avoiding Patterns
When to Speak to Your Doctor
Staying aware of changes in your joint pain or hot flashes can help you and your care team make timely adjustments. For an at-home check, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool guides you through specific questions and offers tailored suggestions before you speak with your doctor.
Although joint pain and hot flashes are common with letrozole, certain signs require immediate medical evaluation:
If you experience any of these, contact your healthcare provider or seek emergency care right away.
Staying proactive and maintaining open communication with your care team will help you manage letrozole side effects effectively and maintain your quality of life throughout treatment.
(References)
* Harbeck N, Haidinger R. The patient experience. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):91-103. doi: 10.1007/s10549-007-9703-8. 2007 Oct 3. PMID: 17912639; PMCID: PMC2001217.
* Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014 Jul 10;371(2):119-29. doi: 10.1056/NEJMoa1313517. PMID: 25006718; PMCID: PMC4175743.
* Yamaguchi M, Erdenebaatar C, Saito F, Motohara T, Miyahara Y, Tashiro H, Katabuchi H. Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma. Int J Gynecol Cancer. 2015 Nov;25(9):1645-51. doi: 10.1097/IGC.0000000000000557. PMID: 26495759.
* Hack CC, Häberle L, Brucker SY, Janni W, Volz B, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kuemmel S, Martin B, Thomssen C, Graf H, Wolf C, Lux MP, Bayer CM, Rauh C, Almstedt K, Gass P, Heindl F, Brodkorb T, Willer L, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Rack B, Beckmann MW, Fehm T, Rody A, Maass N, Hein A, Fasching PA, Nabieva N. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients. Breast. 2020 Apr;50:11-18. doi: 10.1016/j.breast.2019.12.017. 2020 Jan 8. PMID: 31958661; PMCID: PMC7377331.
* Fong MK, Patel P. Aromatase Inhibitors. 2026 Jan. PMID: 32491779.
* Borrie AE, Rose FA, Choi YH, Perera FE, Read N, Sexton T, Lock M, Vandenberg TA, Hahn K, Younus J, Logan D, Potvin K, Yaremko B, Yu E, Lenehan J, Welch S, Teft WA, Kim RB. Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast Cancer Res Treat. 2020 Sep;183(2):365-372. doi: 10.1007/s10549-020-05777-1. 2020 Jul 6. PMID: 32632513.
* Collin A, Vein J, Wittrant Y, Pereira B, Amode R, Guillet C, Richard D, Eschalier A, Balayssac D. A new clinically-relevant rat model of letrozole-induced chronic nociceptive disorders. Toxicol Appl Pharmacol. 2021 Aug 15;425:115600. doi: 10.1016/j.taap.2021.115600. 2021 Jun 1. PMID: 34081940.
* Del Mastro L, Mansutti M, Bisagni G, Ponzone R, Durando A, Amaducci L, Campadelli E, Cognetti F, Frassoldati A, Michelotti A, Mura S, Urracci Y, Sanna G, Gori S, De Placido S, Garrone O, Fabi A, Barone C, Tamberi S, Bighin C, Puglisi F, Moretti G, Arpino G, Ballestrero A, Poggio F, Lambertini M, Montemurro F, Bruzzi P, Gruppo Italiano Mammella investigators. Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021 Oct;22(10):1458-1467. doi: 10.1016/S1470-2045(21)00352-1. 2021 Sep 17. PMID: 34543613.
* Baba O, Kisaoglu H, Kalyoncu M. Letrozole-induced inflammatory arthritis and tendinopathy in pediatric rheumatology setting. Int J Rheum Dis. 2023 Nov;26(11):2314-2316. doi: 10.1111/1756-185X.14748. 2023 May 23. PMID: 37218595.
* Weterings MA, Glanville E, van Eekelen R, Farquhar C. Interventions for fertility preservation in women with cancer undergoing chemotherapy. Cochrane Database Syst Rev. 2025 Jun 19;6(6):CD012891. doi: 10.1002/14651858.CD012891.pub2. 2025 Jun 19. PMID: 40536056; PMCID: PMC12177921.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.